SONIC HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.44 AUD | 0.00% |
|
-4.68% | -20.70% |
| May. 22 | Jarden Adjusts Sonic Healthcare Price Target to AU$26.19 From AU$28.88, Keeps at Neutral | MT |
| May. 21 | Sonic Healthcare Forecasts AU$1.6 Billion EBITDA, AU$8.9 Billion of Revenue for FY2024 | MT |
| Sales 2024 * | 8.84B 5.84B | Sales 2025 * | 9.37B 6.19B | Capitalization | 12.22B 8.07B |
|---|---|---|---|---|---|
| Net income 2024 * | 498M 329M | Net income 2025 * | 572M 378M | EV / Sales 2024 * | 1.69 x |
| Net Debt 2024 * | 2.71B 1.79B | Net Debt 2025 * | 2.65B 1.75B | EV / Sales 2025 * | 1.59 x |
| P/E ratio 2024 * |
24.4
x | P/E ratio 2025 * |
21.3
x | Employees | 41,000 |
| Yield 2024 * |
3.72% | Yield 2025 * |
3.8% | Free-Float | 95.78% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sonic Healthcare Limited
More recommendations
More press releases
More news
| 1 week | -4.68% | ||
| Current month | -4.97% | ||
| 1 month | -3.82% | ||
| 3 months | -12.19% | ||
| 6 months | -11.97% | ||
| Current year | -20.70% |
1 week
23.58
27.10
1 month
23.5827.62
Current year
23.5832.57
1 year
23.5836.34
3 years
23.5846.95
5 years
20.0646.95
10 years
16.5046.95
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 69 | 92-12-31 | |
| Director of Finance/CFO | 65 | 89-11-30 | |
Stephen Fairy
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 69 | 92-12-31 | |
| Director of Finance/CFO | 65 | 89-11-30 | |
Kathryn Spargo
BRD | Director/Board Member | 72 | 10-06-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.76% | 17 M€ | 0.00% | ||
| 0.58% | 120 M€ | +2.36% | - | |
| 0.55% | 1,083 M€ | +3.43% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 25.44 | +3.63% | 2,087,834 |
| 24-05-22 | 24.55 | -1.84% | 3,633,190 |
| 24-05-21 | 25.01 | -6.01% | 6,660,434 |
| 24-05-20 | 26.61 | -0.08% | 1,027,522 |
| 24-05-17 | 26.63 | -1.52% | 848,384 |
Delayed Quote Australian S.E., May 23, 2024 at 05:12 pm EDT
More quotes
Sonic Healthcare Limited is an Australia-based healthcare provider. The Company is engaged in laboratory medicine / pathology, radiology, and primary care medical services, across operations in Australia, Europe, and North America. The Company operates through three segments: Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Radiology technologies include Magnetic resonance imaging (MRI), Computed tomography (CT), Ultrasound, X-ray, Mammography, and others. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. The Company's provides services to clinicians, hospitals, community health services, and their patients. The Company has more than 120 radiology centers.
Calendar
2024-08-21
- Q4 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
25.44
AUD
Average target price
27.62
AUD
Spread / Average Target
+8.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -20.70% | 7.83B | |
| +0.14% | 2.58B | |
| -8.23% | 2.48B | |
| -40.47% | 2.46B | |
| -14.15% | 1.84B | |
| -20.84% | 1.53B | |
| -42.17% | 1.22B | |
| +16.01% | 1.2B | |
| +14.92% | 961M | |
| -15.23% | 920M |
- Stock Market
- Equities
- SHL Stock
